BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reynaert H, Urbain D, Geerts A. Regulation of sinusoidal perfusion in portal hypertension. Anat Rec (Hoboken). 2008;291:693-698. [PMID: 18484616 DOI: 10.1002/ar.20669] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Kowalewska PM, Patrick AL, Fox-Robichaud AE. Innate immunity of the liver microcirculation. Cell Tissue Res 2011;343:85-96. [PMID: 21049273 DOI: 10.1007/s00441-010-1058-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
2 马骁, 孙立涛, 牛芳芳, 张晓卉, 刘冰熔. 门静脉注入扩血管药物对肝硬化大鼠门脉血流动力学的影响. 世界华人消化杂志 2010; 18(33): 3508-3514 [DOI: 10.11569/wcjd.v18.i33.3508] [Reference Citation Analysis]
3 Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, Zhao XY, Ji Y, Li C, Guo L, Zhou L, Chen Z, Leon-Mimila P, Chung MT, Kurabayashi K, Opp J, Campos-Pérez F, Villamil-Ramírez H, Canizales-Quinteros S, Lyons R, Lumeng CN, Zhou B, Qi L, Huertas-Vazquez A, Lusis AJ, Xu XZS, Li S, Yu Y, Li JZ, Lin JD. Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. Mol Cell 2019;75:644-660.e5. [PMID: 31398325 DOI: 10.1016/j.molcel.2019.07.028] [Cited by in Crossref: 148] [Cited by in F6Publishing: 145] [Article Influence: 148.0] [Reference Citation Analysis]
4 Unemori E. Serelaxin in clinical development: past, present and future. Br J Pharmacol 2017;174:921-32. [PMID: 28009437 DOI: 10.1111/bph.13695] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
5 Matsuda M, Seki E. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis. Semin Liver Dis 2020;40:307-20. [PMID: 32242330 DOI: 10.1055/s-0040-1708876] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
6 Castro PR, Barbosa AS, Pereira JM, Ranfley H, Felipetto M, Gonçalves CAX, Paiva IR, Berg BB, Barcelos LS. Cellular and Molecular Heterogeneity Associated with Vessel Formation Processes. Biomed Res Int 2018;2018:6740408. [PMID: 30406137 DOI: 10.1155/2018/6740408] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
7 Aller MA, Arias N, Peral I, García-Higarza S, Arias JL, Arias J. Embrionary way to create a fatty liver in portal hypertension. World J Gastrointest Pathophysiol 2017; 8(2): 39-50 [PMID: 28573066 DOI: 10.4291/wjgp.v8.i2.39] [Reference Citation Analysis]
8 Fernández-Iglesias A, Gracia-Sancho J. How to Face Chronic Liver Disease: The Sinusoidal Perspective. Front Med (Lausanne) 2017;4:7. [PMID: 28239607 DOI: 10.3389/fmed.2017.00007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
9 Meijer EM, van Dijk CGM, Kramann R, Verhaar MC, Cheng C. Implementation of Pericytes in Vascular Regeneration Strategies. Tissue Eng Part B Rev 2021. [PMID: 33231500 DOI: 10.1089/ten.TEB.2020.0229] [Reference Citation Analysis]
10 El Taghdouini A, Najimi M, Sancho-Bru P, Sokal E, van Grunsven LA. In vitro reversion of activated primary human hepatic stellate cells. Fibrogenesis Tissue Repair 2015;8:14. [PMID: 26251672 DOI: 10.1186/s13069-015-0031-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
11 Mottelson MN, Lundsgaard CC, Møller S. Mechanisms in fluid retention - towards a mutual concept. Clin Physiol Funct Imaging 2020;40:67-75. [PMID: 31823451 DOI: 10.1111/cpf.12615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Galler K, Schleser F, Fröhlich E, Requardt RP, Kortgen A, Bauer M, Popp J, Neugebauer U. Exploitation of the hepatic stellate cell Raman signature for their detection in native tissue samples. Integr Biol 2014;6:946-56. [DOI: 10.1039/c4ib00130c] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
13 Yang YY, Huang YT, Lin HC, Lee FY, Lee KC, Chau GY, Loong CC, Lai CR, Lee SD. Thalidomide decreases intrahepatic resistance in cirrhotic rats. Biochem Biophys Res Commun. 2009;380:666-672. [PMID: 19285019 DOI: 10.1016/j.bbrc.2009.01.160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
14 Wei L, Yang J, Wang M, Xu SN, Liang HM, Zhou Q. Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study. Int J Mol Med. 2014;34:1257-1267. [PMID: 25174394 DOI: 10.3892/ijmm.2014.1905] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Liu J, Peng L, Yang J, Wang M, Xu S, Liu J, Han P, He J, Tian D, Zhou Q. Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats. Dig Dis Sci. 2015;60:2019-2029. [PMID: 25724163 DOI: 10.1007/s10620-015-3544-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
16 Jalan R, De Chiara F, Balasubramaniyan V, Andreola F, Khetan V, Malago M, Pinzani M, Mookerjee RP, Rombouts K. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. J Hepatol. 2016;64:823-833. [PMID: 26654994 DOI: 10.1016/j.jhep.2015.11.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
17 Guo CJ, Pan Q, Xiong H, Qiao YQ, Bian ZL, Zhong W, Sheng L, Li H, Shen L, Hua J, Ma X. Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension? Biomed Res Int 2014;2014:797898. [PMID: 24812632 DOI: 10.1155/2014/797898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Wang Y, Ma J, Chen L, Xie X, Jiang H. Inhibition of Focal Adhesion Kinase on Hepatic Stellate-cell Adhesion and Migration. The American Journal of the Medical Sciences 2017;353:41-8. [DOI: 10.1016/j.amjms.2016.11.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
19 You K, Li SY, Gong J, Fang JH, Zhang C, Zhang M, Yuan Y, Yang J, Zhuang SM. MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling. Mol Ther Nucleic Acids. 2018;12:57-66. [PMID: 30195793 DOI: 10.1016/j.omtn.2018.04.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
20 Aerts M, Benteyn D, Van Vlierberghe H, Thielemans K, Reynaert H. Current status and perspectives of immune-based therapies for hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 253-261 [PMID: 26755874 DOI: 10.3748/wjg.v22.i1.253] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
21 Holm A, Heumann T, Augustin HG. Microvascular Mural Cell Organotypic Heterogeneity and Functional Plasticity. Trends in Cell Biology 2018;28:302-16. [DOI: 10.1016/j.tcb.2017.12.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 15.3] [Reference Citation Analysis]
22 Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 1-87. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 马骁, 刘冰熔. 门静脉高压药物治疗的新进展. 世界华人消化杂志 2008; 16(33): 3775-3781 [DOI: 10.11569/wcjd.v16.i33.3775] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
24 Hellerbrand C. Hepatic stellate cells--the pericytes in the liver. Pflugers Arch. 2013;465:775-778. [PMID: 23292551 DOI: 10.1007/s00424-012-1209-5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 9.8] [Reference Citation Analysis]
25 Levitt DG, Levitt MD. Quantitative modeling of the physiology of ascites in portal hypertension. BMC Gastroenterol 2012;12:26. [PMID: 22453061 DOI: 10.1186/1471-230X-12-26] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
26 Garbuzenko DV, Arefyev NO, Belov DV. Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis. World J Hepatol 2016; 8(16): 665-672 [PMID: 27326313 DOI: 10.4254/wjh.v8.i16.665] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
27 Wang F, Jia Y, Li M, Wang L, Shao J, Guo Q, Tan S, Ding H, Chen A, Zhang F, Zheng S. Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells. Cell Commun Signal 2019;17:11. [PMID: 30744642 DOI: 10.1186/s12964-019-0324-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
28 Kitto LJ, Henderson NC. Hepatic Stellate Cell Regulation of Liver Regeneration and Repair. Hepatol Commun 2021;5:358-70. [PMID: 33681672 DOI: 10.1002/hep4.1628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mahmoud AA, Hassan EZ, Askar EM. Long-term influence of sialoadenectomy on the liver of male albino rat. Ultrastruct Pathol 2017;41:265-74. [PMID: 28506098 DOI: 10.1080/01913123.2017.1319886] [Reference Citation Analysis]